Latest News for: cing

Edit

Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E�

Nasdaq Globe Newswire 02 Jul 2026
CEO Shane Schaffer. Inclusion Demonstrates Continued Growth and Enhanced Visibility Among Institutional Investors. CEO Shane Schaffer. Inclusion Demonstrates Continued Growth and Enhanced Visibility Among Institutional Investors ... .
Edit

State investment in CING a “conscious choice" which will continue, President says

CNA 02 Jul 2026
State investment in the Cyprus Institute of Neurology and Genetics (CING) ...
Edit

Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E® (Form 8-K) (Cingulate Inc)

Public Technologies 02 Jul 2026
CING) Added to Russell 3000E® ... CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of ...
Edit

Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E® (Cingulate Inc)

Public Technologies 02 Jul 2026
CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical ...
  • 1

Article Search

tools
×
×
×
×